IRMD

NASDAQ Healthcare

iRadimed Corporation - Common Stock

Medical Devices

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

๐ŸŽฏ Investment Strategy Scores

IRMD scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 81/100โ–ผ -9
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 77/100โ–ผ -13
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 9/100โ–ฒ +9
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿš€ Moon Shot (81/100) โ€” this strategy High growth potential (high beta + oversold).

Lowest fit among scored strategies: ๐ŸŽˆ Over-Hyped (9/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find IRMD in your text

Paste any article, transcript, or post โ€” the tool will extract IRMD and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.